TARSTarsus Pharmaceuticals, Inc.Nov 3, 2026Q3 2026
Read transcript →Tarsus Pharmaceuticals, Inc. (TARS) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$67.75
-1.25%
Mkt Cap $3.50B
TARSTarsus Pharmaceuticals, Inc.Nov 3, 2026TARSTarsus Pharmaceuticals, Inc.Aug 6, 2026Q2 2026
Read transcript →TARSTarsus Pharmaceuticals, Inc.May 6, 2026Q1 2026
Read transcript →TARSTarsus Pharmaceuticals, Inc.Feb 24, 2026Q4 2025
Read transcript →TARSTarsus Pharmaceuticals, Inc.Nov 4, 2025Q3 2025
Read transcript →TARSTarsus Pharmaceuticals, Inc.Aug 7, 2025Q2 2025
Read transcript →TARSTarsus Pharmaceuticals, Inc.May 1, 2025Q1 2025
Read transcript →TARSTarsus Pharmaceuticals, Inc.Feb 25, 2025Q4 2024
Read transcript →TARSTarsus Pharmaceuticals, Inc.Nov 13, 2024Q3 2024
Read transcript →TARSTarsus Pharmaceuticals, Inc.Aug 10, 2024Q2 2024
Read transcript →TARSTarsus Pharmaceuticals, Inc.May 8, 2024Q1 2024
Read transcript →TARSTarsus Pharmaceuticals, Inc.Feb 27, 2024Q4 2023
Read transcript →TARSTarsus Pharmaceuticals, Inc.Nov 10, 2023Q3 2023
Read transcript →